Overview

Welcome to Dwaey, specifically on ZYNOVATE-M Cream page.
This medicine contains an important and useful components, as it consists of Mometasone Furoate - Miconazole Nitrate.
ZYNOVATE-M is available in the market in concentration 0.1% w/w, 2% w/w and in the form of Cream.

OMAN PHARMACEUTICAL PRODUCTS CO. L.L.C (ZYNOVA) is the producer of ZYNOVATE-M and it is imported from OMAN, The most popular alternatives of ZYNOVATE-M are listed downward .

Mode Of Action & Indication

Mometasone depresses the formation, release and activity of endogenous inflammatory chemical mediators (e.g. kinins, histamine, liposomal enzymes and prostaglandin). It inhibits the margination and subsequent cell migration to the injury site, reverses vascular dilatation and permeability, resulting in decreased access of cells to the area of injury.

Indication

• Psoriasis
• Corticosteroid- responsive dermatoses

Precaution

If irritation develops with the use of Mometasone Furoate cream, treatment should be discontinued. Lactation: use caution

Side Effects

• Burning
• Pruritus
• Itching
• Rosacea and skin atrophy may occur.

Contra indication

The drug is contraindicated in individuals with a history of sensitivity reactions to Mometasone or any of the components of the preparation.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks